A clinical study to compare the effect of Lekhaniya Mahakashay through oral administration and Sarwang Swedan in cases of Dyslipidemia.

Abstract

Medoroga is a metabolic disease, which is encountered in routine clinical practice nowadays. Hyperlipidemia involves abnormally elevated levels of any or all lipids and/or lipoproteins in the blood. In our body, there are many tissues which are rich in lipids such as medo dhatu, vasa and majja dhatu. Among the above lipids medo dhatu is very important, as it has a significant role in developing many metabolic diseases. The pathology – due to Meda-Dhatwagni Mandya there is excessive accumulation of Meda that leads to obstruction of Medovaha Strotasa. Due to this, there is excess homologues poshaka medo dhatu in circulation, which can be referred to the conditions such as hyperlipidemia. In this research the effect of lekhaniya mahakashay is compared in sarwang swedan as well as in oral medication along with dasang gugglu in cases of hyperlipidemia because it may be very convenient to patient to use it as oral medication rather than sarwang swedan.